Encefalopatía neonatal. Algo más que asfixia al nacer
Neonathal encefhalopathy something more that perinatal asphysia
Palabras clave:
encefalopatías, hiperglicinemia no cetósica (HGNC), errores innatos del metabolismo (EIM), fenotipo. (es)brain diseases, hyperglycinemia, nonketotic, metabolism, inborn errors (IEM), phenotype (en)
Referencias
Hamosh A, Johnston MV. Nonketotic hyperglycinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill 8th Ed; 2001: 2065-2078.
Casas Fernández C. Aspectos más recientes de la genética de las epilepsias. Rev Neurol. 2000; 30 (supl 1) : S46 - S59.
Hayasaka K, Tada K, Fueki N. Nonketotic hyperglycinemia: Analysis of glycine cleavage system in typical and atypical cases. J Pediatr 1987; 110: 873-877.
Zammarchi E, Donati MA, Ciani F. Transient Neonatal Nonketotic Hyperglycinemia: A 13-year follow up. Neuroped 1995; 26: 328.
Vaquerizo J, Rincón P, Sánchez J, Gómez H, Alejo J, Cardesa JJ. Non-ketotic hyperglycinemia. Transient neonatal form. Rev Neurol 1996; 24: 293-295.
Tendero A, López V, Arcas J, Roche MC, Martínez A. Neonatal EEG trace of burst suppression. Etiological and evolutionary factors. Rev Neurol 2001; 33: 514-8.
Wang PJ, Lee WT, Hwu WL, Young C, Yau KI, Shen YZ. The controversy regarding diagnostic criteria for early myoclonic encephalopathy. Brain Dev. 1998; 20: 530-5.
Bruel H, Boulloche J, Chabrolle JP, Layet V, Poinsot J. Early myoclonic epileptic encephalopathy and non-ketotic hyperglycemia in the same family. Arch Pediatr 1998; 5: 397-9.
Chen PT, Young C, Lee WT, Wang PJ, Peng SS, Shen YZ. Early epileptic encephalopathy with suppression burst electroencephalographic pattern-an analysis of eight Taiwanese patients. Brain Dev 2001; 23: 715-20.
Lu Fl, Wang PJ, Hwu Wl, Tou Yav KL, Wang TR. Neonatal type of nonketotic hyperglycinemia. Pediatr Neurol. 1999; 20: 295-300.
Paupe A, Bidat L, Sonigo P, Lenclen R, Molho M, Ville Y. Prenatal diagnosis of hypoplasia of the corpus callosum in association with non-ketotic hyperglycinemia. Ultrasound in Obstetrics & Gynecology 2002; 20: 616.
Mitsui H, Takahashi S, Higano S, Matsumoto K, Shimanuki Y, Ishibashi C, et al. MR imaging findings of nonketotic hyperglycinemia. 2 cases of neonatal onset. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54: 1047-8.
Rogers T, al-Rayess M, O´Shea P, Ambler MW. Dysplasia of the corpus callosum in identical twins with nonketotic hyperglycinemia. Pediatr Pathol 1991; 11: 897-902.
Press GA, Barshop BA, Haas RH, Nyhan WL, Glass RF, Hesselink JR. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. Am J Neuroradiol 1989; 10:315-21.
Van Hove JL, Kishnani PS, Demaerel P, Kahler SG, Miller C, Jaeken J et al. Acute hydrocephalus in nonketotic hyperglycemia. Neurology 2000; 54: 754-6.
Kure S, Rolland MO, Leisti J, Mandel H, Sakata Y, Tada K et al. Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenat Diagn 1999 ; 19: 717-20.
Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DK, Bemis G. Non-concordance of CVS and liver glycine cleavage enzyme in three families with non-ketotic hyperglycinaemia (NKH) leading to false negative prenatal diagnoses. Prenat Diagn 2000; 20: 367-70.
Arneson D, Chien LT, Chance P, Wilroy RS. Strychnine therapy in nonketotic hyperglycinemia. Pediatrics 1979; 63: 369-373.
L von Wendt L, Simila S, Saukkonen Al, Koivisto M. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia . Pediatrics 1980; 65: 1166-1169.
Matalon R, Naidu S, Hughes J, Michals K. Nonketotic hyperglycinemia: treatment with diazepam-a competitor for glycine receptors. Pediatrics 1983; 71: 581.
Thio LL, Shanmugam A, Isenberg K, Yamada K. Benzodiazepines Block a2- Containing Inhibitory Glycine Receptors in Embryonic Mouse Hippocampal Neurons. J Neurophysiol 2003 ; 90: 89-99.
Alemzadeh R, Gammeltoft K, Matteson K. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia. Pediatrics 1980; 65: 1166-1169.
Hamosh A, Maher JF, Belhs GA, Rasmussen SA, Hohston MV. Long term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998; 132: 709-713.
Alemzadeh R, Gammeltoft K, Matteson K. Efficacy of Low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia. Ped 1996; 97: 924.
Martin-Ancel A, Garcia-Alix A, Gaya F, Cabanas F, Burgueros M, Quero J. Multiple organ involvement in perinatal asphyxia. J Pediatr 1995; 127: 786-93.
Hankins GD, Koen S, Gei AF, López SM, Van Hook JW, Anderson GD. Neonatal organ system injury in acute birth asphyxia sufficient to result in neonatal encephalopathy. Obstet Gynecol 2002; 99: 688-91.
ACOG Press Release, January 31, 2003.
Feiden W, Bratzke H, Scharschmidt A. Birth injury or congenital brain damage? A case of apparent birth injury with globoid cell leukodystrophy (Krabbe´s disease). Geburtshilfe Frauenheilkd 1991; 51: 65-6.
Willis TA, Davidson J, Gray RG, Poulton K, Ramani P, Whitehouse W. Cytochrome oxidase deficiency presenting as birth asphyxia. Dev Med Child Neurol 2000; 42: 414-7.
Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. PEDIATRICS 2000; 105: e10.
Baldellou A, López J, Rebage V, Salazar MI. Mesa redonda: Errores Congénitos del Metabolismo de Presentación Precoz. Anales Españoles de Pediatría 1998; 20-3.
Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF. Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization- Tandem Mass Spectrometry: Results, Outcome, and Implications. PEDIATRICS 2003; 111: 1399-1406.
Burton BK. Inborn errors of metabolism in infancy: A guide to diagnosis. Pediatrics 1998; 102 : 69.
Ciani F, Pasquini E, Ciardetti A, Donati MA, Zammarchi E. Hyperglycinemia in clinical-laboratory practice Pediatr Med Chir 1997; 19: 109-12.
Bermúdez M, Arteaga C, Cifuentes Y, Espinosa E, Uribe A, Barrera LA et al. Hiperglicinemia no cetósica (HGNC) forma típica y atípica. Presentación de casos diagnosticados en Colombia. Pediatría 2001; 36: 123-26.
Martínez A, Roche MC, López V, Arcas J, Tendero A. Trazado EEG neonatal de salva-supresión. Factores etiológicos y evolutivos. Rev Neurol 2001; 33: 514.
Visitas a la página del resumen del artículo
Descargas
Cómo citar
Licencia
Derechos de autor 2007 Revista de la Facultad de Medicina

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
-








